Abstract #3911

MR-Spectroscopic Imaging in the Spotlight of the 2016 WHO Classification

Elie Diamandis¹, Carl Philipp Simon Gabriel², Horst Urbach³, Irina Mader¹, and Dieter Henrik Heiland⁴

¹Department of Neuroradiology, Medical Center Freiburg, Freiburg, Germany, ²Department of Neuroradiology, Medical Center Freiburg, Freibrug, Germany, ³Department of Neuroradiology, Medical Center Freiburg, Frieburg, Germany, ⁴Department of Neurosurgery, Medical Center Freiburg, Freiburg, Germany

The purpose of this study is to map spatial metabolite differences across the three molecular subgroups of glial tumors, defined by the IDH1/2 mutation and 1p19q-co-deletion, using chemical shift imaging. The classification was based on a radiomic approach to the spectroscopic data.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.